TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 77 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392,752 | +13.2% | 22,102 | +15.1% | 0.00% | – |
| Q2 2023 | $346,926 | +84.5% | 19,199 | +28.3% | 0.00% | – |
| Q1 2023 | $188,000 | +112474.9% | 14,969 | +31.9% | 0.00% | – |
| Q4 2022 | $167 | -99.9% | 11,351 | +13.0% | 0.00% | – |
| Q3 2022 | $172,000 | +21.1% | 10,042 | +3.6% | 0.00% | – |
| Q2 2022 | $142,000 | +111.9% | 9,693 | +145.1% | 0.00% | – |
| Q1 2022 | $67,000 | -98.3% | 3,954 | -97.7% | 0.00% | – |
| Q4 2021 | $3,932,000 | +5517.1% | 174,736 | +5298.1% | 0.00% | – |
| Q3 2021 | $70,000 | -53.3% | 3,237 | -37.3% | 0.00% | – |
| Q2 2021 | $150,000 | -57.4% | 5,162 | -52.7% | 0.00% | – |
| Q1 2021 | $352,000 | -49.3% | 10,912 | -35.0% | 0.00% | – |
| Q4 2020 | $694,000 | – | 16,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |